99 related articles for article (PubMed ID: 23452506)
1. Adherence therapy following an acute episode of schizophrenia: a multi-centre randomised controlled trial.
Schulz M; Gray R; Spiekermann A; Abderhalden C; Behrens J; Driessen M
Schizophr Res; 2013 May; 146(1-3):59-63. PubMed ID: 23452506
[TBL] [Abstract][Full Text] [Related]
2. Adherence therapy following acute exacerbation of schizophrenia: A randomised controlled trial in Thailand.
von Bormann S; Robson D; Gray R
Int J Soc Psychiatry; 2015 Feb; 61(1):3-9. PubMed ID: 24691494
[TBL] [Abstract][Full Text] [Related]
3. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
[TBL] [Abstract][Full Text] [Related]
5. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.
Chien WT; Mui JH; Cheung EF; Gray R
Trials; 2015 Jun; 16():270. PubMed ID: 26072311
[TBL] [Abstract][Full Text] [Related]
6. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
Maneesakorn S; Robson D; Gournay K; Gray R
J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
[TBL] [Abstract][Full Text] [Related]
7. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
8. Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial.
Chien WT; Mui J; Gray R; Cheung E
BMC Psychiatry; 2016 Feb; 16():42. PubMed ID: 26911397
[TBL] [Abstract][Full Text] [Related]
9. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS).
Farooq S; Nazar Z; Irfan M; Akhter J; Gul E; Irfan U; Naeem F
Br J Psychiatry; 2011 Dec; 199(6):467-72. PubMed ID: 22130748
[TBL] [Abstract][Full Text] [Related]
11. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
12. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
[TBL] [Abstract][Full Text] [Related]
13. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
14. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
[TBL] [Abstract][Full Text] [Related]
15. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
16. Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study.
De la Gándara J; San Molina L; Rubio G; Rodriguez-Morales A; Hidalgo Borrajo R; Burón JA
Expert Rev Neurother; 2009 Oct; 9(10):1463-74. PubMed ID: 19831836
[TBL] [Abstract][Full Text] [Related]
17. Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.
Ascher-Svanum H; Weiden P; Nyhuis AW; Faries DE; Stauffer V; Kollack-Walker S; Kinon BJ
Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):84-90, 90A. PubMed ID: 23446198
[TBL] [Abstract][Full Text] [Related]
18. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders.
Jäger M; Riedel M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Huff W; Heuser I; Kühn KU; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Bottlender R; Strauss A; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2007 Feb; 257(1):47-53. PubMed ID: 17033915
[TBL] [Abstract][Full Text] [Related]
19. Shared decision making with schizophrenic patients: a randomized controlled clinical trial with booster sessions (DECIDE Study).
Pérez-Revuelta JI; González-Sáiz F; Pascual-Paño JM; Mongil-San Juan JM; Rodríguez-Gómez C; Muñoz-Manchado LI; Mestre-Morales J; Berrocoso E; Villagrán Moreno JM
Patient Educ Couns; 2023 May; 110():107656. PubMed ID: 36807126
[TBL] [Abstract][Full Text] [Related]
20. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
